James Fink

Chief Scientific Officer

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

James Fink is the Chief Scientific Officer at Aerogen Pharma Corp in the United States. His research focuses on aerosol delivery systems, mechanical ventilation, and the effects of various respiratory therapies, particularly in the context of pulmonary diseases and COVID-19. His recent publications include studies on aerosol drug delivery efficiency and the impacts of ventilation modes on treatment efficacy.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Ratko Djukanovic

University of Southampton

UNITED KINGDOM

View details

Jie Li

Rush University

UNITED STATES

View details

Howard Clark

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Fink

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Long COVID: Ventilation and Perfusion Are Reduced in Symptomatic Individuals Compared to Asymptomatic Patients—A V/Q Scintigraphy Study

Aerosol Delivery to an Adult Model via High-Flow Nasal Cannula with Inspiration-Synchronized Small-Particle Vibrating Mesh Nebulizer

In Vitro Comparison of Inspiration-Synchronized and Continuous Vibrating Mesh Nebulizer During Adult Invasive Mechanical Ventilation

The Effects of Inspiratory Flows, Inspiratory Pause, and Suction Catheter on Aerosol Drug Delivery with Vibrating Mesh Nebulizers During Mechanical Ventilation

Effect of Interrupting Heated Humidification on Nebulized Drug Delivery Efficiency, Temperature, and Absolute Humidity During Mechanical Ventilation: A Multi-Lab In Vitro Study

Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilators in the Treatment of Intubated Adult Patients with Obstructive Pulmonary Disease

Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial

Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen

Reliability of Mesh Aerosol Devices Used During INHALE Trial

Does Valved Holding Chamber Improve Aerosol Lung Deposition with a Jet Nebulizer? A Randomized Crossover Study

Quantifying Delivered Dose with Jet and Mesh Nebulizers during Spontaneous Breathing, Noninvasive Ventilation, and Mechanical Ventilation in a Simulated Pediatric Lung Model with Exhaled Humidity

In Vitro Evaluation of a Vibrating-Mesh Nebulizer Repeatedly Use over 28 Days

Optimal Connection for Tiotropium SMI Delivery through Mechanical Ventilation: An In Vitro Study

Collaborators (3)

Ratko Djukanovic

Jie Li

Howard Clark

Make your next move.